Nifty
Sensex
:
:
11407.15
37930.77
150.05 (1.33%)
537.29 (1.44%)

Pharmaceuticals & Drugs

Rating :
50/99

BSE: 500288 | NSE: MOREPENLAB

18.55
-0.30 (-1.59%)
17-May-2019 | 3:59PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  18.85
  •  19.00
  •  18.30
  •  18.85
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  339284
  •  62.94
  •  37.10
  •  14.55

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 838.93
  • 29.08
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 847.54
  • N/A
  • 3.31

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 34.54%
  • 4.09%
  • 40.49%
  • FII
  • DII
  • Others
  • 0.43%
  • 13.39%
  • 7.06%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.08
  • 10.79
  • 7.42

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 38.09
  • 5.64
  • -1.26

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 18.29

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 33.49
  • 45.93
  • 42.02

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.81
  • 4.11
  • 4.50

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 16.76
  • 16.51
  • 17.39

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 19
Mar 18
Var%
Dec 18
Dec 17
Var%
Sep 18
Sep 17
Var%
Jun 18
Jun 17
Var%
Net Sales
218.72
0.00
0.00
212.16
0.00
0.00
173.94
0.00
0.00
163.73
0.00
0.00
Expenses
196.97
0.00
0.00
195.32
0.00
0.00
157.18
0.00
0.00
151.55
0.00
0.00
EBITDA
21.75
0.00
0.00
16.83
0.00
0.00
16.76
0.00
0.00
12.18
0.00
0.00
EBIDTM
9.94%
0.00%
7.93%
0.00%
9.64%
0.00%
7.44%
0.00%
Other Income
1.03
0.00
0.00
2.43
0.00
0.00
0.13
0.00
0.00
0.08
0.00
0.00
Interest
0.93
0.00
0.00
0.43
0.00
0.00
0.32
0.00
0.00
0.44
0.00
0.00
Depreciation
11.15
0.00
0.00
9.80
0.00
0.00
9.79
0.00
0.00
9.16
0.00
0.00
PBT
10.70
0.00
0.00
9.04
0.00
0.00
6.79
0.00
0.00
2.65
0.00
0.00
Tax
0.21
0.00
0.00
0.13
0.00
0.00
-0.19
0.00
-
0.19
0.00
0.00
PAT
10.49
0.00
0.00
8.91
0.00
0.00
6.97
0.00
0.00
2.46
0.00
0.00
PATM
4.80%
0.00%
4.20%
0.00%
4.01%
0.00%
1.50%
0.00%
EPS
0.23
0.00
0.00
0.20
0.00
0.00
0.16
0.00
0.00
0.05
0.00
0.00

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Net Sales
768.55
606.51
595.47
485.08
400.64
366.85
325.92
289.34
228.30
211.86
184.05
Net Sales Growth
0.00%
1.85%
22.76%
21.08%
9.21%
12.56%
12.64%
26.74%
7.76%
15.11%
 
Cost Of Goods Sold
496.51
361.28
358.35
293.33
238.62
209.04
193.53
178.07
142.68
127.05
115.10
Gross Profit
272.04
245.23
237.12
191.76
162.02
157.81
132.39
111.27
85.62
84.80
68.96
GP Margin
35.40%
40.43%
39.82%
39.53%
40.44%
43.02%
40.62%
38.46%
37.50%
40.03%
37.47%
Total Expenditure
701.02
541.78
534.09
423.52
352.41
317.95
294.97
270.11
222.53
200.23
180.02
Power & Fuel Cost
-
11.08
9.84
7.64
7.41
8.42
8.96
9.82
7.69
6.01
6.08
% Of Sales
-
1.83%
1.65%
1.57%
1.85%
2.30%
2.75%
3.39%
3.37%
2.84%
3.30%
Employee Cost
-
76.53
69.69
58.29
48.79
45.08
39.17
36.05
30.52
23.48
20.81
% Of Sales
-
12.62%
11.70%
12.02%
12.18%
12.29%
12.02%
12.46%
13.37%
11.08%
11.31%
Manufacturing Exp.
-
16.21
22.36
13.33
12.68
12.23
11.33
10.20
11.40
9.19
8.22
% Of Sales
-
2.67%
3.76%
2.75%
3.16%
3.33%
3.48%
3.53%
4.99%
4.34%
4.47%
General & Admin Exp.
-
28.52
18.11
18.14
15.89
16.62
13.86
14.37
12.72
13.24
11.93
% Of Sales
-
4.70%
3.04%
3.74%
3.97%
4.53%
4.25%
4.97%
5.57%
6.25%
6.48%
Selling & Distn. Exp.
-
30.04
25.79
23.45
21.40
19.55
20.40
15.85
11.26
18.13
14.74
% Of Sales
-
4.95%
4.33%
4.83%
5.34%
5.33%
6.26%
5.48%
4.93%
8.56%
8.01%
Miscellaneous Exp.
-
18.11
29.95
9.35
7.61
7.01
7.72
5.75
6.26
3.12
14.74
% Of Sales
-
2.99%
5.03%
1.93%
1.90%
1.91%
2.37%
1.99%
2.74%
1.47%
1.71%
EBITDA
67.52
64.73
61.38
61.56
48.23
48.90
30.95
19.23
5.77
11.63
4.03
EBITDA Margin
8.79%
10.67%
10.31%
12.69%
12.04%
13.33%
9.50%
6.65%
2.53%
5.49%
2.19%
Other Income
3.67
3.72
3.72
1.20
1.37
1.22
2.87
1.18
1.04
0.33
1.42
Interest
2.12
4.36
7.56
10.50
8.66
9.92
11.63
7.96
6.27
4.03
2.66
Depreciation
39.90
34.32
33.90
35.20
38.67
45.84
45.80
48.06
48.16
48.02
52.14
PBT
29.18
29.77
23.63
17.06
2.28
-5.64
-23.61
-35.61
-47.62
-40.10
-49.34
Tax
0.34
0.00
0.00
-0.13
0.14
0.01
-0.01
0.06
-0.69
0.03
0.63
Tax Rate
1.17%
0.00%
0.00%
-1.03%
6.14%
-0.36%
0.05%
-0.25%
1.45%
-0.48%
-1.53%
PAT
28.83
29.59
23.63
12.80
2.14
-2.77
-20.52
-23.65
-46.93
-6.22
-41.76
PAT before Minority Interest
28.84
29.77
23.63
12.80
2.14
-2.75
-20.52
-23.63
-46.93
-6.27
-41.93
Minority Interest
0.01
-0.18
0.00
0.00
0.00
-0.02
0.00
-0.02
0.00
0.05
0.17
PAT Margin
3.75%
4.88%
3.97%
2.64%
0.53%
-0.76%
-6.30%
-8.17%
-20.56%
-2.94%
-22.69%
PAT Growth
0.00%
25.22%
84.61%
498.13%
-
-
-
-
-
-
 
Unadjusted EPS
0.64
0.66
0.53
0.28
0.04
-0.07
-0.45
-0.54
-1.04
-0.15
-1.17

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Shareholder's Funds
225.94
196.26
300.28
287.48
297.11
299.88
320.40
344.05
390.99
292.50
Share Capital
89.96
89.96
209.61
209.61
209.61
209.61
209.61
209.61
209.61
191.11
Total Reserves
135.98
106.30
90.67
77.87
87.50
90.27
110.79
134.44
181.38
98.69
Non-Current Liabilities
20.20
17.80
57.47
74.00
84.65
103.91
122.05
135.01
139.74
280.45
Secured Loans
2.95
1.38
43.41
62.27
74.78
94.65
98.85
114.37
128.45
136.88
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
15.04
14.32
11.29
143.58
Long Term Provisions
14.42
13.59
11.34
9.22
7.82
7.17
5.73
3.90
0.00
0.00
Current Liabilities
340.12
324.86
166.56
127.92
108.14
102.73
104.95
102.78
85.24
80.87
Trade Payables
174.88
124.88
115.33
84.96
68.60
56.81
64.98
59.79
82.18
77.81
Other Current Liabilities
163.90
198.65
47.04
39.87
37.58
45.22
38.96
41.11
0.00
0.11
Short Term Borrowings
0.00
0.00
0.00
2.23
1.19
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
1.33
1.33
4.19
0.86
0.77
0.70
1.01
1.88
3.06
2.95
Total Liabilities
585.81
538.29
523.68
489.00
489.50
506.09
546.98
581.40
615.53
653.46
Net Block
264.29
271.80
296.72
322.48
368.08
409.46
451.86
496.02
540.18
583.44
Gross Block
997.60
1,026.96
1,018.43
1,009.35
1,004.61
1,000.44
997.38
997.96
995.54
991.31
Accumulated Depreciation
733.31
755.15
721.72
686.87
636.53
590.98
545.52
501.94
455.35
407.88
Non Current Assets
338.68
346.34
366.53
374.42
393.18
415.00
457.37
501.38
544.15
587.41
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investment
0.00
0.00
0.00
0.00
0.00
3.87
3.87
3.97
3.97
3.97
Long Term Loans & Adv.
74.12
73.69
69.82
51.94
25.10
1.67
1.64
1.39
0.00
0.00
Other Non Current Assets
0.27
0.85
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
247.13
191.95
157.15
114.58
96.32
91.09
89.61
80.02
69.96
64.65
Current Investments
0.22
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
76.89
64.66
42.14
37.11
33.30
37.05
38.66
34.70
31.68
22.29
Sundry Debtors
121.85
92.95
87.94
56.14
42.67
39.11
35.15
29.64
23.83
21.22
Cash & Bank
5.95
7.59
4.36
8.85
9.11
5.53
4.51
2.58
1.10
4.59
Other Current Assets
42.23
4.71
5.94
3.14
11.24
9.40
11.29
13.10
13.34
16.55
Short Term Loans & Adv.
36.61
22.03
16.77
9.34
8.23
6.23
9.60
10.30
11.19
14.71
Net Current Assets
-92.99
-132.92
-9.41
-13.34
-11.82
-11.64
-15.34
-22.76
-15.28
-16.22
Total Assets
585.81
538.29
523.68
489.00
489.50
506.09
546.98
581.40
615.53
653.47

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Cash From Operating Activity
63.41
40.73
50.07
50.70
33.52
33.64
27.11
11.13
6.67
-3.48
PBT
29.86
23.04
17.06
2.28
-5.64
-23.60
-35.61
-47.62
-40.10
-49.34
Adjustment
38.55
41.40
45.69
47.32
55.76
56.80
55.99
54.44
51.68
54.37
Changes in Working Capital
-5.00
-23.72
-8.41
1.23
-19.50
-2.64
-5.25
3.63
-4.50
-7.88
Cash after chg. in Working capital
63.41
40.73
54.34
50.83
30.62
30.56
15.13
10.45
7.08
-2.85
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
0.00
0.00
0.13
-0.13
0.01
0.01
-0.06
0.68
-0.03
-0.63
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
-4.40
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-26.93
-13.60
-27.30
-31.65
-0.80
-2.83
-3.35
-4.05
-4.43
-1.37
Net Fixed Assets
31.96
-8.08
-7.02
-4.73
-4.09
-2.87
0.60
-2.41
-4.29
8.76
Net Investments
-0.22
0.00
0.25
0.00
3.87
0.00
0.10
0.00
0.00
0.00
Others
-58.67
-5.52
-20.53
-26.92
-0.58
0.04
-4.05
-1.64
-0.14
-10.13
Cash from Financing Activity
-37.77
-23.72
-27.26
-19.31
-29.14
-29.79
-21.83
-5.60
-5.72
-5.84
Net Cash Inflow / Outflow
-1.29
3.40
-4.49
-0.26
3.58
1.02
1.93
1.48
-3.48
-10.68
Opening Cash & Equivalents
7.00
3.60
8.85
9.11
5.53
4.51
2.58
1.10
4.59
15.27
Closing Cash & Equivalent
5.72
7.00
4.36
8.85
9.11
5.53
4.51
2.58
1.10
4.59

Financial Ratios

Consolidated /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Book Value (Rs.)
5.02
4.36
4.02
3.73
3.95
4.01
4.46
4.99
6.00
4.72
ROA
5.30%
4.45%
2.53%
0.44%
-0.55%
-3.90%
-4.19%
-7.84%
-0.99%
-6.17%
ROE
14.10%
12.54%
7.35%
1.24%
-1.54%
-10.77%
-11.12%
-18.99%
-2.86%
-21.90%
ROCE
14.05%
10.18%
6.29%
2.90%
1.80%
-2.09%
-3.40%
-8.22%
-0.40%
-6.44%
Fixed Asset Turnover
0.60
0.58
0.49
0.41
0.37
0.33
0.29
0.23
0.21
0.18
Receivable days
64.63
55.44
53.22
44.17
40.16
40.83
40.35
42.17
38.81
33.63
Inventory Days
42.59
32.73
29.27
31.48
34.55
41.63
45.68
52.36
46.50
41.04
Payable days
103.38
82.97
83.88
76.01
67.69
69.30
75.59
101.91
124.72
123.16
Cash Conversion Cycle
3.85
5.20
-1.39
-0.36
7.02
13.16
10.44
-7.39
-39.41
-48.49
Total Debt/Equity
0.06
0.25
0.22
0.28
0.30
0.37
0.38
0.39
0.36
0.97
Interest Cover
7.83
4.13
2.21
1.26
0.72
-0.77
-1.96
-6.59
-0.55
-14.52

News Update:


  • Morepen Laboratories reports 51% jump in export sales revenue in Q4FY19
    6th May 2019, 09:44 AM

    The company’s API sales revenue grew by 34% at Rs 125.48 crore

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.